Evaluation of Clinical Equivalence Between Two Lubiprostone Products
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the clinical equivalence and safety of the Test
formulation of lubiprostone 24 mcg capsules compared to the marketed formulation AMITIZA®
(lubiprostone) 24 mcg capsules (Sucampo Pharmaceuticals, Inc.) in patients with confirmed
chronic idiopathic constipation.